Japanese Red Cross Medical Center

Shibuya City, Tokyo 150-8935

0 studies enrolling now · 1 studies all time

What they study most

MDS, Myelodysplastic Syndrome, RAEB, Refractory Anemia With Excess Blasts

Studies at this site

• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early